Hard to tell from that - most of that profit could be revaluation of biological assets and inventory. No dividend - but does look hopeful for generating good cashflows in future periods. Guess we should get more prior to opening today. Meanwhile the NTA per share is a helpful guide to valuation in the absence of a dividend.
Ann: Appendix 4D, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 85468 | 9.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 59624 | 2 |
View Market Depth
| Last trade - 10.19am 28/06/2024 (20 minute delay) ? |
| ATP (ASX) Chart |
Day chart unavailable